Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients
with cancer. The risk of VTE varies over the natural history of cancer, with the highest risk …

Background: Venous thromboembolism prophylaxis has been recommended for
nonsurgical patients, but its effectiveness remains uncertain. Purpose: To assess the …

Venous thromboembolism (VTE) represents one of the most important causes of morbidity
and mortality in cancer patients. According to population-based case–control studies, the 2 …

Background Acutely ill hospitalized medical patients are at risk for VTE. We assessed the
incidence of VTE in the observational International Medical Prevention Registry on Venous …

Background The efficacy and safety of prolonging prophylaxis for venous thromboembolism
in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that …

Background Acutely ill, hospitalized medical patients are at risk of VTE. Despite guidelines
for VTE prevention, prophylaxis use in these patients is still poor, possibly because of fear of …

Description: The American College of Physicians (ACP) developed this guideline to present
the evidence and provide clinical recommendations on prophylaxis of venous …

Background Although thromboprophylaxis reduces the incidence of venous
thromboembolism in acutely ill medical patients, an associated reduction in the rate of death …

Background & aims: The use of low‐molecular‐weight heparins (LMWH) in patients with
advanced liver diseases is frequently avoided because of the enhanced risk of bleeding …

BACKGROUND: Fewer than half of eligible hospitalized medical patients receive
appropriate venous thromboembolism (VTE) prophylaxis. One reason for this low rate is the …